Danish diagnostic company Dako is to combine operations with Cytomation, of Fort Collins, Colorado. The deal brings together Cytomation's bioinstrumentation and software with Dako's biotech and diagnostic experience. The unit will be headed by Copenhagen-based Dako's president and CEO, Jes Estergaard, while Nigel Ferrey, Cytomation's president and CEO, will be responsible for US operations. He will also join the corporate management group.
"By combining the strengths of the two companies with Dako's worldwide market reach, we will create an excellent platform for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?